Want to see SDEV full AI Analyst Report?
Top Page
Stablecoin Development Corp
(SDEV)
Select Model
Select Model
Rating:42Neutral
Price Target:
$1.00
▼(-4.04% Downside)
Action:Reiterated
Date:08/26/26
The score is held down primarily by weak financial performance (negative/poor-quality operating profitability and persistent cash burn) and bearish technical trend signals (price below key moving averages with negative MACD). Valuation screens as very low on P/E, but its usefulness is limited given the mismatch between net income and operating results, while corporate events are mixed with non-cash loss drivers offset by balance-sheet and cost-structure improvements.
Positive Factors
Stronger solvency
The cleaner capital structure reduces leverage risk and improves financial flexibility. However, the benefit is tempered by prior periods of negative equity, so the current solvency improvement should be viewed as meaningful but not fully proven.
Negative Factors
Persistent cash burn
Sustained operating and free-cash-flow deficits show that the business is not self-funding. Continued cash consumption may require additional financing or asset sales, limiting strategic flexibility and creating recurring funding risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Stronger solvency
The cleaner capital structure reduces leverage risk and improves financial flexibility. However, the benefit is tempered by prior periods of negative equity, so the current solvency improvement should be viewed as meaningful but not fully proven.
Read all positive factors
Stablecoin Development Corp (SDEV) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$52.64M
Dividend YieldN/A
Average Volume (3M)1.27M
Price to Earnings (P/E)<0.1
Beta (1Y)1.36
Revenue Growth-74.73%
EPS Growth95.81%
CountryUS
Employees4
SectorFinancial
Sector Strength70
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)14.24
Shares Outstanding50,615,437
10 Day Avg. Volume139,927
30 Day Avg. Volume1,267,658
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.32
Price to Sales (P/S)0.00
P/FCF Ratio-0.86
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-1.9
Revenue Forecast (FY)$15.80M
Stablecoin Development Corp Business Overview & Revenue Model
Company Description
Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brand...
Stablecoin Development Corp Earnings Call Summary
Earnings Call Date:Aug 13, 2024
(Q2-2024)
| % Change Since: |
Next Earnings Date:Nov 05, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed outlook, with strong growth and efficiency improvements in the eyecare segment, but challenges in overall revenue and net loss due to declines in wound care sales and low cash reserves.Positive Updates
Eyecare Business Growth
Sales from eyecare products reached $4.8 million for the first half of 2024, showing growth in the eyecare segment driven by Avenova branded products.
Negative Updates
Net Loss
Net loss attributable to common stockholders for Q2 2024 was $1.6 million, compared with a net loss of $4 million for Q2 2023.
Read all updates
Q2-2024 Updates
Positive
Negative
Eyecare Business Growth
Sales from eyecare products reached $4.8 million for the first half of 2024, showing growth in the eyecare segment driven by Avenova branded products.
Read all positive updates
Company Guidance
During the NovaBay Pharmaceuticals Q2 2024 earnings call, the company reported a strong performance in its eyecare segment, with sales of eyecare products reaching $4.8 million for the first half of the year. They are on track to meet their annual target of $10 million in eyecare sales. The company has successfully reduced sales and marketing expenses by 13% year-over-year while achieving an 8% increase in eyecare revenue for Q2 2024, primarily through online OTC channels. Subscribe & Save customers on Amazon, their largest sales channel, grew by 16% in the first half of 2024, contributing to approximately 24% of online Avenova revenue. The gross margin improved to 66% in Q2 2024 from 49% in the prior year due to a shift towards higher-margin eyecare products. NovaBay's strategic focus remains on efficient growth within the U.S. dry eye market, anticipated to exceed $4.8 billion by 2030.Stablecoin Development Corp Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
58
Neutral
Cash Flow
18
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.67M | 0.00 | 0.00 | 10.46M | 14.40M | 10.20M |
| Gross Profit | 4.62M | -140.00K | -341.00K | 6.08M | 7.78M | 6.51M |
| EBITDA | -6.54M | -7.45M | -7.04M | -3.75M | -7.20M | -8.74M |
| Net Income | 483.44M | -641.98M | -7.22M | -6.14M | -10.61M | -5.82M |
Balance Sheet | ||||||
| Total Assets | 127.51M | 10.65M | 45.91M | 50.42M | 16.40M | 23.98M |
| Cash, Cash Equivalents and Short-Term Investments | 7.12M | 7.96M | 430.00K | 2.92M | 5.36M | 7.50M |
| Total Debt | 0.00 | 776.00K | 1.67M | 2.61M | 2.04M | 551.00K |
| Total Liabilities | 270.00K | 33.47M | 46.03M | 47.10M | 5.84M | 13.81M |
| Stockholders Equity | 127.24M | -22.83M | -129.00K | 3.31M | 10.55M | 10.17M |
Cash Flow | ||||||
| Free Cash Flow | -11.88M | -8.43M | -7.50M | -4.28M | -6.77M | -9.24M |
| Operating Cash Flow | -11.88M | -8.43M | -7.50M | -4.26M | -6.65M | -9.19M |
| Investing Cash Flow | -33.50M | 0.00 | 0.00 | -19.00K | -112.00K | -12.04M |
| Financing Cash Flow | 46.66M | 4.62M | 1.50M | 1.91M | 4.63M | 16.79M |
Stablecoin Development Corp Technical Analysis
Negative
1.04
Price Trends
1.13
Negative
1.27
Negative
7.26
Negative
Market Momentum
-0.03
Negative
41.79
Neutral
31.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SDEV, the sentiment is Negative. The current price of 1.04 is below the 20-day moving average (MA) of 1.04, below the 50-day MA of 1.13, and below the 200-day MA of 7.26, indicating a bearish trend. The MACD of -0.03 indicates Negative momentum. The RSI at 41.79 is Neutral, neither overbought nor oversold. The STOCH value of 31.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SDEV.
Stablecoin Development Corp Risk Analysis
Stablecoin Development Corp disclosed 54 risk factors in its most recent earnings report. Stablecoin Development Corp reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Stablecoin Development Corp Peers Comparison
UnderperformOutperform
Sector (68)
SDEV
Stablecoin Development Corp
0.97
-4.15
-81.06%
AIXC
AIxCrypto Holdings
0.92
-0.90
-49.51%
CIRC
Circle8 Group
0.65
-3.64
-84.85%
Stablecoin Development Corp Corporate Events
Business Operations and StrategyFinancial Disclosures
Stablecoin Development Corp Posts Q2 Loss Amid SKY Decline
Negative
Jul 31, 2026
On July 31, 2026, Stablecoin Development Corporation reported second-quarter 2026 results showing $2.2 million in staking revenue and a $53.8 million operating loss, largely driven by a $50.6 million non-cash unrealized loss from the decline in SK...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Stablecoin Development Names Henry Blynn as New COO
Positive
Jul 17, 2026
On July 15, 2026, Stablecoin Development Corporation’s board appointed Henry Blynn, previously Head of Business Operations and Strategy, as Chief Operating Officer, formalizing his leadership role with an amended employment agreement dated J...
Private Placements and FinancingRegulatory Filings and Compliance
Stablecoin Development Expands Equity Base After Warrant Exercises
Neutral
Jun 17, 2026
On June 12 and June 15, 2026, Stablecoin Development Corporation amended pre-funded warrants originally issued in October 2025 to R01 Fund LP and Framework Ventures IV L.P., removing certain restrictions on exercisability. Following these amendmen...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.